Literature DB >> 19319551

A possible ambivalent role for relaxin in human myometrial and decidual cells in vitro.

Dunja M Baston-Büst1, Alexandra P Hess, Jens Hirchenhain, Jürgen Krücken, Frank Wunderlich, Jan S Krüssel, Ulrike K Friebe-Hoffmann.   

Abstract

PURPOSE: Based on the reported tocolytic action of the hormone relaxin (RLX) in rodents, locally produced in reproductive tissues and the corpus luteum in mammals, the present study aimed to evaluate the influence of RLX on contraction-mediating cyclooxygenases-1 and -2 (COX) and the contractile prostaglandin PGE(2) in human myometrial and decidual cells. Primary cultured cells were obtained from uteri and placentas of term and preterm women undergoing elective caesarean section.
METHODS: In vitro culture of primary myometrial and decidual cells, immunocytochemistry, reverse transcription and real-time PCR, Western blot, ELISA.
RESULTS: We demonstrate for the first time an activating effect of RLX for human COX-1 and COX-2 in primary myometrial and decidual cells in vitro.
CONCLUSIONS: These effects might potentially contribute to birth-associated induction of contractions in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319551     DOI: 10.1007/s00404-009-1046-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Regulation of sPLA2-IID in Human Decidua: Insights Into the Complexity of the Prostaglandin Pathway in Labor.

Authors:  Andrea A Mosher; Kelly J Rainey; Brigitta Riley; Hayley S Levinson; Angela E Vinturache; Stephen L Wood; Donna M Slater
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

2.  Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns.

Authors:  Dunja M Baston-Büst; Martin Götte; Wolfgang Janni; Jan-Steffen Krüssel; Alexandra P Hess
Journal:  Reprod Biol Endocrinol       Date:  2010-11-02       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.